A Phase IV, Randomized, Observer-blind, Active-controlled, Single-Center Study to Evaluate Lot to Lot Consistency and Immunogenicity and Safety of an Inactivated TriValent Split Seasonal Influenza Virus Vaccine (TY flu) in Healthy Chinese Subjects Aged 3 Years and above
Latest Information Update: 22 Apr 2016
At a glance
- Drugs Influenza virus vaccine (Primary) ; TY 01 (Primary)
- Indications Influenza virus infections
- Focus Pharmacodynamics
- Sponsors Zhejiang Tianyuan Bio-pharmaceutical
- 07 Aug 2013 New trial record